Evolving Concepts of Pulmonary Hypertension Secondary to Left Heart Disease. (Q38737284)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26886381%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Evolving Concepts of Pulmonary Hypertension Secondary to Left Heart Disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26886381%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

main subject

pulmonary hypertension

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26886381%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26886381%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Bhavadharini Ramu

1 reference

6 September 2017

Thenappan Thenappan

series ordinal

1 reference

6 September 2017

publication date

1 April 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26886381%20AND%20SRC:MED&resulttype=core&format=json

Current heart failure reports

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26886381%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26886381%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26886381%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

92-102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26886381%20AND%20SRC:MED&resulttype=core&format=json

Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Updated Clinical Classification of Pulmonary Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Vulnerability of Pulmonary Capillaries in Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Left ventricular dysfunction with pulmonary hypertension: Part 1: epidemiology, pathophysiology, and definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Lung capillary injury and repair in left heart disease: a new target for therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Pathophysiology and clinical relevance of pulmonary remodelling in pulmonary hypertension due to left heart diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: heart failure causes severe lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Mitral regurgitation in patients with advanced systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Usefulness of the pulmonary arterial systolic pressure to predict pulmonary arterial wedge pressure in patients with normal left ventricular systolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Age- and gender-related ventricular-vascular stiffening: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

The arterial load in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Prognostic role of pulmonary arterial capacitance in advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Pulmonary Arterial Capacitance Is an Important Predictor of Mortality in Heart Failure With a Preserved Ejection Fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Pulmonary capillary wedge pressure augments right ventricular pulsatile loading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Right heart dysfunction in heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Right ventricular response to intensive medical therapy in advanced decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Echocardiographic assessment of pulmonary artery systolic pressure and outcomes in ambulatory heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Prognostic significance of exercise-induced right ventricular dysfunction in asymptomatic degenerative mitral regurgitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Pulmonary hypertension in advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Age-associated increases in pulmonary artery systolic pressure in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Association of the metabolic syndrome with pulmonary venous hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Determinants of pulmonary hypertension in left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Determinants of exercise-induced pulmonary hypertension in patients with normal left ventricular ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Noninvasive identification of left-sided heart failure in a population suspected of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

LA volume by CMR distinguishes idiopathic from pulmonary hypertension due to HFpEF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Definitions and diagnosis of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

High prevalence of occult left heart disease in scleroderma-pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Endothelium-dependent pulmonary artery responses in chronic heart failure: influence of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Positive inotropic effect of endothelin-1 in the neonatal mouse right ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Pulmonary edema caused by inhaled nitric oxide therapy in two patients with pulmonary hypertension associated with the CREST syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Pilot assessment of the response of several pulmonary hemodynamic variables to sublingual sildenafil in candidates for heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0284-X

Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management

21 January 2018

1 reference

12 December 2020

Prognostic Importance of Various Echocardiographic Right Ventricular Functional Parameters in Patients with Symptomatic Heart Failure

1 reference

12 December 2020

Functional mitral regurgitation: a link to pulmonary hypertension in heart failure with preserved ejection fraction

1 reference

12 December 2020

Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure

1 reference

12 December 2020

Pulmonary hypertension due to left heart disease

1 reference

12 December 2020

Acute hemodynamic and neurohumoral effects of selective ET(A) receptor blockade in patients with congestive heart failure. ET 003 Investigators

1 reference

12 December 2020

Quantification of right ventricular afterload in patients with and without pulmonary hypertension

1 reference

12 December 2020

The influence of heart rate on pulmonary arterial-left ventricular pressure relationships at end-diastole

1 reference

12 December 2020

Invasive and non-invasive determinants of pulmonary hypertension in patients with chronic heart failure

1 reference

12 December 2020

Discerning Pulmonary Venous From Pulmonary Arterial Hypertension Without the Help of a Catheter

1 reference

12 December 2020

Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure

1 reference

12 December 2020

Pulmonary arterial capacitance in patients with heart failure and reactive pulmonary hypertension

1 reference

12 December 2020

Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure

1 reference

12 December 2020

Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction

1 reference

12 December 2020

Relation of pulmonary arterial diastolic and mean pulmonary arterial wedge pressures in patients with and without pulmonary hypertension

1 reference

12 December 2020

Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure

1 reference

12 December 2020

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

12 December 2020

Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure

1 reference

12 December 2020

Chronic sildenafil lowers transpulmonary gradient and improves cardiac output allowing successful heart transplantation

1 reference

12 December 2020

Prevalence of, Associations With, and Prognostic Value of Tricuspid Annular Plane Systolic Excursion (TAPSE) Among Out-Patients Referred for the Evaluation of Heart Failure

1 reference

12 December 2020

Right ventricular function in patients with preserved and reduced ejection fraction heart failure

1 reference

12 December 2020

Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure

1 reference

12 December 2020

Pulmonary hypertension due to left heart diseases.

1 reference

12 December 2020

Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis

1 reference

12 December 2020

The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease

1 reference

12 December 2020

Noninvasive differentiation of pulmonary arterial and venous hypertension using conventional and Doppler tissue imaging echocardiography

1 reference

12 December 2020